'''Etamiphylline''' or '''etamiphyllin''' ([[International nonproprietary name|INN]])<ref name="INN">{{cite web | title = International Non-Proprietary Names for Pharmaceutical Preparations. Recommended International Non-Proprietary Names (Rec. I.N.N.): List 3 | url = http://www.who.int/medicines/publications/druginformation/innlists/RL03.pdf | publisher = World Health Organization | accessdate = 29 December 2016 | page = 467}}</ref> is a [[xanthine]] intended for use as an anti-[[asthma]] agent. It has shown poor to absent effects in human clinical trials.<ref>{{Cite journal | last1 = Vazquez | first1 = C | last2 = Labayru | first2 = T | last3 = Rodriguez-Soriano | first3 = J | title = Poor bronchodilator effect of oral etamiphylline in asthmatic children | journal = Lancet | volume = 1 | issue = 8382 | page = 914 | year = 1984 | pmid = 6143224 | doi=10.1016/s0140-6736(84)91380-1}}</ref><ref>{{Cite journal | last1 = Addis | first1 = GJ | title = Absence of bronchodilatory effect from etamiphylline | journal = Lancet | volume = 1 | issue = 8385 | page = 1083 | year = 1984 | pmid = 6144017 | doi=10.1016/s0140-6736(84)91497-1}}</ref>
